Most actively traded companies on the TSX, TSX Venture Exchange

TORONTO – Some of the most active companies traded Tuesday on the Toronto Stock Exchange and the TSX Venture Exchange:

Toronto Stock Exchange (14,525.19, up 10.45 points):

Fortis Inc. (TSX:FTS.IR). Utilities. Up 40 cents, or 1.07 per cent, to $37.90 on 12.2 million shares.

Balmoral Resources Ltd. (TSX:BAR). Miner. Up 22 cents, or 20.37 per cent, to $1.30 on 4.8 million shares.

B2Gold Corp. (TSX:BTO). Miner. Up seven cents, or 2.44 per cent, to $2.94 on 4.8 million shares.

Bombardier Inc. (TSX:BBD.B). Transportation. Up two cents, or 0.51per cent, to $3.92 on 3.9 million shares.

Twin Butte Energy Ltd. (TSX:TBE). Oil and gas. Up one cent, or 0.55 per cent, to $1.82 on 3.4 million shares.

Cenovus Energy Inc. (TSX:CVE). Oil and gas. Down eight cents, or 0.25 per cent, to $31.34 on 2.6 million shares.

Toronto Venture Exchange (970.15, down 6.40 points):

Petromanas Energy Inc. (TSXV:PMI). Oil and gas. Up three cents, or 11.11 per cent, to 30 cents on 3.9 million shares.

Eaglewood Energy Inc. (TSXV:EWD). Oil and gas. Up three cents, or 8.82 per cent, to 37 cents on 3.4 million shares.

Companies reporting major news:

Valeant Pharmaceutical International Inc. (TSX:VRX). Drug manufacturer. Up $5.14, or 3.73 per cent, to $142.76 on 506,297 shares. The Quebec-based company says it will begin its latest offensive to acquire Botox-maker Allergan next week. The company plans tosweeten its US$47-billion bid and hold a “referendum” this summer to convince the U.S. company’s board and management that Allergan shareholders want a merger between the two pharmaceutical companies.

Velan Inc. (TSX:VLN). Industrial products. Up 90 cents, or 5.59 per cent, to $17 on 4,467 shares. The Montreal-based company industrial valve maker is increasing its dividend by 25 per cent after swinging to a profit in its fiscal fourth quarter despite a drop in revenue. Velan said it earned US$10.4 million or 47 cents a share in the three months ended Feb. 28, reversing a loss of US$3.6 million or 16 cents per share in the comparable year-earlier period even as sales fell 15.1 per cent or US$21.4 million to US$120.7 million.